𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus

✍ Scribed by Anna Kramvis; Kazuko Arakawa; Mimi C. Yu; Ramon Nogueira; Daniel O. Stram; Michael C. Kew


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
928 KB
Volume
80
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Using phylogenetic analysis and pairwise comparison of 670 complete hepatitis B virus (HBV) genomes, we demonstrated that nucleotide divergence greater than 7.5% can be used to separate strains into genotypes A–H. Strains can be separated into subgenotypes when two criteria are met: nucleotide divergence of about 4% but less than 7.5% and good bootstrap support. There is a highly statistically significant association between serological subtypes and genotypes (Ο‡^2^‐test for association, P < 0.0001): adw is associated with genotypes A, B, F, G, and H, adr with C and ayw with D and E. The logistic regression method showed that 1802–1803CG are characteristic of genotypes A, D, and E whereas 1802–1803TT are characteristic of genotypes B, C, and F. 1858C is positively associated with genotypes A, F, and H and 1858T with genotypes B, D, and E. Subgenotypes C2, F1/F4 can be differentiated from subgenotypes C1, F2/F3, respectively, because the latter have 1858C as opposed to 1858T in the former. 1888A was positively associated with subgenotype A1 and TAA at 1817 with genotype G. The Haploplot method revealed high linkage between loci 1858 and 1896 but strong evidence of recombination between loci 1862 and 1896. Loci 1809–1812, 1862, and 1888 may have co‐evolved. Using a computer program, we showed that serological subtype deduced from the S region (position 155–835) and mutations/variations within the basic core promoter/precore region (1653–1900), allowed genotyping of HBV with 97% sensitivity and 99% specificity. Certain subgenotypes or subgenotype groups could also be differentiated. J. Med. Virol. 80:27–46, 2008. Β© 2007 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Precore/core promoter mutations and geno
✍ Chun-Jen Liu; Jia-Horng Kao; Ming-Yang Lai; Pei-Jer Chen; Ding-Shinn Chen πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 77 KB πŸ‘ 2 views

## Abstract The association of precore stop codon mutation (A1896), dinucleotide mutation (T1762/A1764) in the basic core promoter of hepatitis B virus (HBV) genome, and genotype of HBV with fulminant or subfulminant hepatitis remains controversial. We studied HBV genotypes as well as mutations in

Hepatitis B virus BCP, precore/core, X g
✍ Mohammad Asim; Abdul Malik; Manash P. Sarma; Sunil K. Polipalli; Nargis Begum; I πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 1 views

## Abstract The study aims to characterize mutations of the HBV genome involving BCP, Precore/core and X regions and also defines HBV genotypes in patients of hepatocellular carcinoma (HCC). The study involved 150 HBV‐related HCC cases and 136 HBV‐related chronic liver disease patients without HCC

Specific mutations in the enhancer II/co
✍ Ja Kyung Kim; Hye Young Chang; Jung Min Lee; Oidov Baatarkhuu; Young Joon Yoon; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 1 views

## Abstract Recently, hepatitis B virus (HBV) genotypes and mutations have been reported to be related to hepatocellular carcinoma (HCC). This cross‐sectional case–control study examined the relationship between HCC and mutations in the enhancer II/core promoter and precore regions of HBV by compar

Genetic heterogeneity of the precore and
✍ Reiichiro Kuwahara; Ryukichi Kumashiro; Shiro Murashima; Kei Ogata; Kazuo Tanaka πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

It has been reported that spontaneous or interferon (IFN)-induced hepatitis B e (HBe) seroconversion has usually been associated with the development of a stop codon in the precore region. However, the difference between lamivudine-induced seroconversion and spontaneous or IFN-induced seroconversion